Faculty Articles
What Are We Treating With Antihyperglycaemic Drug Therapy?
ISBN or ISSN
1759-8893
Publication Title
Journal of Pharmaceutical Health Services Research
Volume
9
Issue
3
Publication Date / Copyright Date
9-2018
First Page
173
Last Page
174
Publisher
Oxford Academic
DOI Number
10.1111/jphs.12260
Abstract
Excerpt
Diabetes produces one of the biggest economic and health burdens in the United States. The total estimated cost of diabetes in 2017 was $327 billion, an increase of 26% when compared to 2012.[1] Cardiovascular and chronic kidney disease and death are major complications of type 2 diabetes.[2] Specifically, cardiovascular disease is currently one of the leading causes of morbidity and mortality in this population and the largest contributor to the direct and indirect costs of diabetes.[2,3] At least 68% of people aged 65 or older with diabetes die from some form of heart disease.[3] Furthermore, diabetes is the seventh leading cause of death in the United States.
Disciplines
Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences
Keywords
cardiovascular disease, diabetes, economics, health, kidney disease, older adults, United States
NSUWorks Citation
Perez Rivera, Alexandra and Wertheimer, Albert, "What Are We Treating With Antihyperglycaemic Drug Therapy?" (2018). Faculty Articles. 387.
https://nsuworks.nova.edu/hpd_corx_facarticles/387
